DOJ Sues Drugmaker Over Unapproved Misbranded Drugs
The U.S. Department of Justice has hit Sage Pharmaceuticals Inc. with a misbranding suit in Louisiana federal court accusing the company of unlawfully manufacturing and selling several drugs without regulatory approval,...To view the full article, register now.
Already a subscriber? Click here to view full article